The Coronary Artery Bypass Graft (CABG) Market is centered on the gold-standard surgical procedure used to treat severe coronary artery disease (CAD) by creating new pathways for blood flow to the heart muscle, bypassing blocked or narrowed coronary arteries using harvested blood vessels (grafts). While traditional CABG involves a sternotomy and the use of a cardiopulmonary bypass (heart-lung) machine, continuous innovation in surgical techniques aims to reduce invasiveness and improve long-term outcomes for patients with multivessel disease.

vascular grafts to improve procedure longevity within the Coronary Artery Bypass Graft Market.

Technological advancements are driving a shift toward Minimally Invasive and Off-Pump CABG (OPCAB), where the procedure is performed on a beating heart without the heart-lung machine, potentially reducing perioperative complications. Furthermore, Robotic-Assisted CABG offers enhanced precision and smaller incisions, leading to faster patient recovery. The critical trend involves the increased use of Total Arterial Grafts (e.g., internal mammary arteries) over venous grafts due to their superior long-term patency rates, with emerging research focusing on hybrid revascularization (combining CABG with percutaneous coronary intervention) and the future potential of bioengineered 

Related Reports